Company Filing History:
Years Active: 2024
Title: Alexandra Rose Grassian: Innovator in Cancer Treatment
Introduction
Alexandra Rose Grassian is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic methods.
Latest Patents
Grassian holds 1 patent for her work titled "Methods of treating cancer by inhibiting SETD2." This patent outlines methods and pharmaceutical compositions aimed at treating or slowing the progression of cancers, specifically pancreatic and esophageal cancer. The invention involves administering a therapeutically effective amount of an inhibitor of the histone methyltransferase, SETD2, to human subjects in need.
Career Highlights
Grassian is currently associated with Epizyme, Inc., a company dedicated to developing innovative therapies for cancer treatment. Her work at Epizyme has positioned her as a key player in the fight against cancer, contributing to advancements in targeted therapies.
Collaborations
Grassian collaborates with notable colleagues, including Michael Thomenius and Jennifer Anne Totman, who share her commitment to advancing cancer research and treatment.
Conclusion
Alexandra Rose Grassian's innovative work in cancer treatment exemplifies the impact of dedicated research and collaboration in the medical field. Her contributions continue to pave the way for new therapeutic approaches to combat cancer effectively.